NCT01801618

National Evaluation of PI-based 2nd Line Efficacy in Cambodia

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 15,001,351 (actual)
• Sponsor: ANRS, Emerging Infectious Diseases · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Medium and long term efficacy of PI-based 2nd line antiretroviral (ARV) therapy in Cambodia is poorly documented when the numbers of patients on treatment and their duration are increasing. For patients in treatment failure , there is no alternative ARV regimen available to date. This operational research aims to evaluate the Cambodian National Program PI-based 2nd line antiretroviral regimen to assess the proportion of treatment failure and drug resistance ;identify the structural and individual factors associated with treatment failure ; design alternative salvage ARV regimens.

Conditions

• HIV

Timeline

• Start date: 2013-02-01
• Primary completion: 2014-07-01
• Completion: 2014-12-01
• First posted: 2013-03-01
• Last updated: 2016-07-21

Locations

13 sites across 1 country: Cambodia